These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27922868)

  • 21. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
    Ranade R; Kand P; Basu S
    Nucl Med Commun; 2015 Oct; 36(10):1014-20. PubMed ID: 26049373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative study about thyroid stunning after diagnostic whole-body scanning with 74 MBq 131I in patients with differentiated thyroid carcinoma.
    Yin Y; Mao Q; Chen S; Li N; Li X; Li Y
    Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):455-61. PubMed ID: 26416037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is osteoid osteoma an iodophilic lesion?: pathologically proved osteoid osteoma of nasal bone first seen on whole-body iodine-131 scan.
    Rachinsky I; Shelef I; Agranovich S; Lantsberg S
    Clin Nucl Med; 2003 Aug; 28(8):696-8. PubMed ID: 12897666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma.
    Sherman SI; Tielens ET; Sostre S; Wharam MD; Ladenson PW
    J Clin Endocrinol Metab; 1994 Mar; 78(3):629-34. PubMed ID: 8126134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan.
    Giovanella L; Suriano S; Ceriani L; Verburg FA
    Clin Nucl Med; 2011 Feb; 36(2):109-12. PubMed ID: 21220971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal thoracic uptake mimicking lung metastasis on 131I post-therapy whole-body scan in patients with thyroid carcinoma.
    Jia C; Moadel R; Freeman LM
    Clin Nucl Med; 2014 Apr; 39(4):360-2. PubMed ID: 24598344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incompletely dissolved radioiodine capsule as a likely cause of false-positive whole-body scan in thyroid cancer.
    Oh JR; Jeong SY; Yoon H
    Clin Nucl Med; 2015 Feb; 40(2):177-8. PubMed ID: 24999704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
    Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
    Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
    Bertagna F; Albano D; Bosio G; Piccardo A; Dib B; Giubbini R
    Curr Radiopharm; 2016; 9(3):228-234. PubMed ID: 27210819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two artifacts in the (131)I whole body post treatment scan in a thyroid cancer patient.
    Sood A; Seam RK; Sood V; Kumar R
    Hell J Nucl Med; 2007; 10(3):184. PubMed ID: 18084663
    [No Abstract]   [Full Text] [Related]  

  • 35. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma.
    Achong DM; Oates E; Lee SL; Doherty FJ
    J Nucl Med; 1991 Dec; 32(12):2275-7. PubMed ID: 1744714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
    Kunawudhi A; Pak-art R; Keelawat S; Tepmongkol S
    Clin Nucl Med; 2012 Jun; 37(6):561-7. PubMed ID: 22614187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial staging of differentiated thyroid carcinoma: continued utility of posttherapy 131I whole-body scintigraphy.
    Donahue KP; Shah NP; Lee SL; Oates ME
    Radiology; 2008 Mar; 246(3):887-94. PubMed ID: 18309016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
    Casara D; Rubello D; Saladini G; Mazzarotto R; Sotti G; Tomasella G; Pelizzo MR
    Tumori; 1999; 85(2):122-7. PubMed ID: 10363078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian dermoid cyst serendipitously detected by pelvic radioiodine-(131)I uptake and by diffusion weighted MRI in a post-thyroidectomy case of papillary thyroid carcinoma.
    Basu S; Mahajan A
    Hell J Nucl Med; 2013; 16(1):62-3. PubMed ID: 23529395
    [No Abstract]   [Full Text] [Related]  

  • 40. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.